These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 24418725

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased retinal neovascularization in Fas ligand-deficient mice.
    Davies MH, Eubanks JP, Powers MR.
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy.
    Cheng G, He T, Xing Y.
    Eye (Lond); 2016 Jun; 30(6):877-87. PubMed ID: 26987588
    [Abstract] [Full Text] [Related]

  • 9. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
    Kociok N, Krohne TU, Poulaki V, Joussen AM.
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J, Afzal A, Pan H, Gallego E, Li N, Li Calzi S, Caballero S, Spoerri PE, Shaw LC, Grant MB.
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Captopril and vascular endothelial growth factor in a mouse model of retinopathy.
    Higgins RD, Yan Y, Geng Y, Sharma J, Barr SM.
    Curr Eye Res; 2003 Aug; 27(2):123-9. PubMed ID: 14632165
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model.
    Mezu-Ndubuisi OJ, Adams T, Taylor LK, Nwaba A, Eickhoff J.
    Eye (Lond); 2019 Mar; 33(3):363-373. PubMed ID: 30209267
    [Abstract] [Full Text] [Related]

  • 16. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice.
    Pan X, Lv Y.
    Ophthalmic Res; 2020 Mar; 63(2):182-193. PubMed ID: 31955159
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP.
    McColm JR, Geisen P, Hartnett ME.
    Mol Vis; 2004 Jul 21; 10():512-20. PubMed ID: 15303088
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression.
    Cheng G, Tian K, Zhang L, Yang N, Xing Y, He T.
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan 21; 254(1):97-108. PubMed ID: 26358273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.